179 related articles for article (PubMed ID: 26292757)
1. An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress.
Quereda V; Porlan E; Cañamero M; Dubus P; Malumbres M
Cell Death Differ; 2016 Mar; 23(3):430-41. PubMed ID: 26292757
[TBL] [Abstract][Full Text] [Related]
2. Genetic cooperation between p21Cip1 and INK4 inhibitors in cellular senescence and tumor suppression.
Quereda V; Martinalbo J; Dubus P; Carnero A; Malumbres M
Oncogene; 2007 Dec; 26(55):7665-74. PubMed ID: 17599058
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
[TBL] [Abstract][Full Text] [Related]
4. Genetic characterization of the role of the Cip/Kip family of proteins as cyclin-dependent kinase inhibitors and assembly factors.
Cerqueira A; Martín A; Symonds CE; Odajima J; Dubus P; Barbacid M; Santamaría D
Mol Cell Biol; 2014 Apr; 34(8):1452-9. PubMed ID: 24515438
[TBL] [Abstract][Full Text] [Related]
5. Cortactin modulates RhoA activation and expression of Cip/Kip cyclin-dependent kinase inhibitors to promote cell cycle progression in 11q13-amplified head and neck squamous cell carcinoma cells.
Croucher DR; Rickwood D; Tactacan CM; Musgrove EA; Daly RJ
Mol Cell Biol; 2010 Nov; 30(21):5057-70. PubMed ID: 20805359
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases.
Barbacid M; Ortega S; Sotillo R; Odajima J; Martín A; Santamaría D; Dubus P; Malumbres M
Cold Spring Harb Symp Quant Biol; 2005; 70():233-40. PubMed ID: 16869759
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
Hsieh FF; Barnett LA; Green WF; Freedman K; Matushansky I; Skoultchi AI; Kelley LL
Blood; 2000 Oct; 96(8):2746-54. PubMed ID: 11023508
[TBL] [Abstract][Full Text] [Related]
8. Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors.
Parry D; Mahony D; Wills K; Lees E
Mol Cell Biol; 1999 Mar; 19(3):1775-83. PubMed ID: 10022865
[TBL] [Abstract][Full Text] [Related]
9. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1).
Martín A; Odajima J; Hunt SL; Dubus P; Ortega S; Malumbres M; Barbacid M
Cancer Cell; 2005 Jun; 7(6):591-8. PubMed ID: 15950907
[TBL] [Abstract][Full Text] [Related]
10. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir I; Polyak K; Iavarone A; Massagué J
Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
[TBL] [Abstract][Full Text] [Related]
11. Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1).
Bagui TK; Jackson RJ; Agrawal D; Pledger WJ
Mol Cell Biol; 2000 Dec; 20(23):8748-57. PubMed ID: 11073976
[TBL] [Abstract][Full Text] [Related]
12. Activation of cyclin D1-kinase in murine fibroblasts lacking both p21(Cip1) and p27(Kip1).
Sugimoto M; Martin N; Wilks DP; Tamai K; Huot TJ; Pantoja C; Okumura K; Serrano M; Hara E
Oncogene; 2002 Nov; 21(53):8067-74. PubMed ID: 12444543
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between Cdk4 and p27kip1 in tumor development: a preclinical model to evaluate cell cycle inhibitors with therapeutic activity.
Sotillo R; Renner O; Dubus P; Ruiz-Cabello J; Martín-Caballero J; Barbacid M; Carnero A; Malumbres M
Cancer Res; 2005 May; 65(9):3846-52. PubMed ID: 15867383
[TBL] [Abstract][Full Text] [Related]
14. Cdk4 and Cdk6 cooperate in counteracting the INK4 family of inhibitors during murine leukemogenesis.
Rodríguez-Díez E; Quereda V; Bellutti F; Prchal-Murphy M; Partida D; Eguren M; Kollmann K; Gómez de Cedrón M; Dubus P; Cañamero M; Martínez D; Sexl V; Malumbres M
Blood; 2014 Oct; 124(15):2380-90. PubMed ID: 25157181
[TBL] [Abstract][Full Text] [Related]
15. P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes.
Bagui TK; Mohapatra S; Haura E; Pledger WJ
Mol Cell Biol; 2003 Oct; 23(20):7285-90. PubMed ID: 14517297
[TBL] [Abstract][Full Text] [Related]
16. Development of mice without Cip/Kip CDK inhibitors.
Tateishi Y; Matsumoto A; Kanie T; Hara E; Nakayama K; Nakayama KI
Biochem Biophys Res Commun; 2012 Oct; 427(2):285-92. PubMed ID: 23000166
[TBL] [Abstract][Full Text] [Related]
17. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines.
Sangfelt O; Erickson S; Einhorn S; Grandér D
Oncogene; 1997 Jan; 14(4):415-23. PubMed ID: 9053838
[TBL] [Abstract][Full Text] [Related]
18. p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest.
Green SL; Freiberg RA; Giaccia AJ
Mol Cell Biol; 2001 Feb; 21(4):1196-206. PubMed ID: 11158306
[TBL] [Abstract][Full Text] [Related]
19. The influence of high glucose on the Cip/Kip family expression profiles in HRECs.
Tian J; Ma H; Luo Y; Hu A; Lin S; Li T; Guo K; Li J; Cai M; Tang S
J Mol Histol; 2013 Dec; 44(6):705-13. PubMed ID: 23636608
[TBL] [Abstract][Full Text] [Related]
20. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors.
Sotillo R; Dubus P; Martín J; de la Cueva E; Ortega S; Malumbres M; Barbacid M
EMBO J; 2001 Dec; 20(23):6637-47. PubMed ID: 11726500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
